‘Don’t you know who I am?’: Why patient identification is so...
When we think patient safety, pharmacists’ minds jump to drug interactions, adverse events or toxic doses. But incorrect patient identification can have equal capacity...
Bumetanide for Alzheimer’s disease
Alzheimer’s disease is the most common form of dementia, affecting up to 70% of all people with dementia.1 In the early stages, symptoms can...
Pharmacists key to respiratory health in extreme weather
The recent dust storms and bushfires in NSW and Queensland serve as a reminder of the escalating effects of climate change, leading to an...
Informing pharmacy practice with valuable research
PSA’s Pharmacists in 2023 vision advocates the implementation of a ‘research culture’ in Australia. Here’s how members can pursue valuable research in their own...
Calcium and Vitamin D for premenopause
The latest findings from a Cochrane review on the benefit of supplementing premenopausal women with calcium and vitamin D.
Background
Osteoporosis (OP) is characterised by porous...
